Targeting MDM4 as a Novel Therapeutic Approach in Prostate Cancer Independent of p53 Status.
Mejía-Hernández JO, Raghu D, Caramia F, Clemons N, Fujihara K, Riseborough T, Teunisse A, Jochemsen AG, Abrahmsén L, Blandino G, Russo A, Gamell C, Fox SB, Mitchell C, Takano EA, Byrne D, Miranda PJ, Saleh R, Thorne H, Sandhu S, Williams SG, Keam SP, Haupt Y, Haupt S.
Mejía-Hernández JO, et al. Among authors: haupt s, haupt y.
Cancers (Basel). 2022 Aug 16;14(16):3947. doi: 10.3390/cancers14163947.
Cancers (Basel). 2022.
PMID: 36010941
Free PMC article.